Startups ink new partnerships

Scantrust has entered into a global agreement with ePAC to provide its scanning technology to develop a new connected packaging and connected goods service. Under the name ePacConnect, the service uses Scantrust serialized and secured QR codes printed on flexible packaging for consumer-packaged goods companies of all sizes. Because every ePacConnect flexible package includes a Scantrust QR code, every product in ePac flexible packages becomes an online gateway. The solution, in turn, activates the Scantrust suite of connected goods and connected packaging tools. The features range from consumer engagement tools to active brand protection anti-counterfeiting features that work through scans of a safe QR code on the packaging. ePacConnect removes barriers to entry for companies that want enterprise-grade branding and packaging design and access to innovations like variable data printing (VDP), serialization, and patented anti-counterfeit features.

Flovtec and VRM
Zug based flovtec, provider of market-making solutions to the digital asset ecosystem participants and VRM, an EU data-based trading financial institution focused on High-Frequencies investment strategies for digital assets, aims to build market-making projects and trading signals, entered a strategic partnership. The two combine their expertise to provide market-making projects and trading signals, offering FLy token holders additional financial services to generate trading income and access to market insights.

iOnctura and research partner Professor Francesco Bertoni research funding
iOnctura SA, a clinical-stage oncology company targeting core resistance and relapse mechanisms at the tumour-stroma-immune interface, announces the support of Innosuisse in a 2-year innovation project to explore the potential of iOnctura’s lead molecule, the PI3Kδ-inhibitor IOA-244, in the treatment of lymphoma. The Innosuisse grant of CHF 596'828 will fund fifty percent of the project’s costs, covering the research carried out by Professor Francesco Bertoni of the Institute of Oncology Research (IOR) in Bellinzona, Switzerland. The new project will explore patient stratification biomarkers, combination interventions to increase lymphoma treatment response rates, and methods for minimizing potential resistance pathways.

Lunaphore and the University of Bern
Lunaphore Technologies SA. and the Translational Research Unit (TRU) of the Institute of Pathology at the University of Bern have received a grant from the impulse program Swiss Innovation Power promoted by Innosuisse, the Swiss Innovation Agency, to pursue a research collaboration. The project aims to study isolated cancer cell clusters, called tumour buds (TB), in colorectal cancer (CRC), using Lunaphore's high-multiplexed immunostaining technology COMET™, to expand our understanding of tumour budding events and improve cancer prognosis as well as personalized medicine. The platform will provide a major leap towards the quantitative and reproducible analysis of TB and the generation of biomarkers for routine prognostic usage in clinical pathology.

Seervision and Kilchenmann
ETH Spinoff Seervision has partnered with Kilchenmann, one of the strongest providers of services for professional audio, video and communication technology as well as total multimedia solutions in Switzerland to deliver video production innovation to customers in Switzerland. Seervision is developing innovative software aimed at making live video production automated and effortless. The Seervision Suite is primarily focused on automating the overall workflow of corporate studios, stage events and education spaces. The startup currently employees 30 employees.

(RAN)